Cargando…
Overexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Patients With Pancreatic Adenocarcinoma
BACKGROUND: Laminin-332 (LM-332, formerly termed laminin-5) is a heterotrimeric glycoprotein that promotes cellular adhesion and migration. The heterotrimer consists of an α3, a β3, and a γ2 chain. The aim of this investigation was to clarify the clinicopathologic significance of laminin-332β3 (LNβ3...
Autores principales: | Chen, Jun, Wang, Weilin, Wei, Jianfeng, Zhou, Dongkai, Zhao, Xinyi, Song, Wei, Sun, Qiang, Huang, Pengfei, Zheng, Shusen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530729/ https://www.ncbi.nlm.nih.gov/pubmed/25032755 http://dx.doi.org/10.1097/PAI.0000000000000115 |
Ejemplares similares
-
Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma
por: Chen, Jun, et al.
Publicado: (2018) -
Autoimmunity against laminin 332
por: Patzelt, Sabrina, et al.
Publicado: (2023) -
Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma
por: Sari, Bilge, et al.
Publicado: (2023) -
Laminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma
por: Huang, Caiqun, et al.
Publicado: (2021) -
Laminin 332 processing impacts cellular behavior
por: Rousselle, Patricia, et al.
Publicado: (2013)